I’m not too sure I think it’s A
Answer:
mimicry
Explanation:
Mimicry -
It is the resemblance in between two organisms of different species or may be of the same species .
The main reason for mimicry is the protection of the species from the predators .
From the question , the beetles in the second case mimic the characteristic of the first beetle , by raising their abdomen , just top protect them selves .
Hence , the correct term for the given question is - mimicry .
Crossing over is the main event in meiosis and heredity as it leads to genetic variation.
<h3>What is genetic variation?</h3>
Genetic variation is the changes that take place in the genes of individuals that can lead to the formation of new characters.
it generally occurs in meiosis specifically during crossing over.
Thus, it can be concluded that crossing over between non-sister chromatids during meiosis is significant in heredity as it leads to genetic variation.
For more details regarding crossing over, visit:
brainly.com/question/27256451
#SPJ4
Answer:
Phase III
Explanation:
The given condition fall in the trial phase (Phase III) of cinical study which aims to:
- Determine drug's effectiveness (primary goal)
- Determine long-term drug safety
- Confirm findings
In Phase III, randomised, double-blind, placebo-controlled, parallel group study is majorly to evaluate the efficacy and safety of placebo in episodic migraine prevention in children (6 to < 12 years of age) and adolescents (12 to < 18 years of age).
The trial consists of four phases: screening; double-blind therapy period for 24 weeks in which placebo or Erenumab is given to subject as dose 1, dose 2 or dose 3 (based on the participant's body weight) once a month via subcutaneous injection; optional dose level blinded extension phase (40 weeks) which involves subjects recieve dose1, 2 and 3 of placebo, and at last it follows a safety follow-up phase for 12 weeks (after 16 weeks of the last dose of investigational drug).
Hence, the clinical phase is phase III.
